Teva, AbbVie Finalize $6.6B Opioid Settlements November 23, 2022 By Brendan Pierson Teva Pharmaceutical Industries Ltd. and AbbVie Inc. have finalized the terms of settlements worth more than $6.6 billion to resolve...
Allergan Poised to Pay More Than $2 Billion in Opioid Settlement July 28, 2022 By Jef Feeley AbbVie Inc.’s Allergan unit has reached an agreement to pay more than $2 billion to resolve thousands of lawsuits filed...
AbbVie Pays $200M to Settle Opioid Marketing Case Right Before Trial Ends December 9, 2021 By Brendan Pierson AbbVie Inc. agreed to pay $200 million to settle claims by New York that its Allergan unit helped fuel an...
Judge Overturns $140M Verdict Against AbbVie, Orders Retrial July 6, 2018 By Nate Raymond A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc. in a lawsuit by a man who...
Jury Finds AbbVie Not Liable in AndroGel Injury Suit January 29, 2018 By Nate Raymond A federal jury in Chicago on Friday found AbbVie Inc. not liable in a lawsuit by an Arizona man who...
Why Patent ‘Shenanigans’ Share Blame for High Cost of Drugs December 29, 2017 By Robert Langreth and Cynthia Koons Bob Kelsey can’t afford a cancer drug that could save his life. The retired firefighter, 53, needs Revlimid to stay...
Judge Nixes $150M Damages Against Testosterone Drugmaker AbbVie December 27, 2017 By Nate Raymond A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc. that was the first to result from...
Chicago Jury Awards $150M in Punitive Damages in Testosterone Lawsuit July 26, 2017 Federal jurors in Chicago say the pharmaceutical company AbbVie should pay $150 million to an Oregon man for misrepresenting the...
Illinois Jury: AbbVie Must Pay $15M in Depakote Birth-Defect Case June 12, 2017 A federal jury in East St. Louis, Ill., has awarded $15 million to a 10-year-old boy whose mother blamed his...
Obama Administration Weighing Options to Curb Corporate Inversions August 6, 2014 By Richard Rubin The U.S. Treasury Department is examining unilateral actions to curb corporate inversions, reversing its position that only Congress has the...